As shown in Figure 5B and Figure S5, when HCC cells were treated with CAPE, a specific inhibitor of NF-κB, TNF-α and HBV lost the ability to regulate the expression of miR-497. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.